RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Retension Pharmaceuticals, Inc.
$16.33+2.26 (+16.06%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
1 of Retension Pharmaceuticals's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 9, 2026 | Oct 13, 2026 | SEC EDGAR |